nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—Behcet's disease	0.837	1	CbGaD
Pranlukast—IL5—Allograft Rejection—MICA—Behcet's disease	0.00875	0.0663	CbGpPWpGaD
Pranlukast—NFKB1—Inflammasomes—MEFV—Behcet's disease	0.00613	0.0464	CbGpPWpGaD
Pranlukast—MUC2—brainstem—Behcet's disease	0.00412	0.133	CbGeAlD
Pranlukast—IL5—Cytokines and Inflammatory Response—IL10—Behcet's disease	0.00378	0.0286	CbGpPWpGaD
Pranlukast—NFKB1—mouth—Behcet's disease	0.0036	0.116	CbGeAlD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.00297	0.0225	CbGpPWpGaD
Pranlukast—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—Behcet's disease	0.00294	0.0223	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—ITGB2—Behcet's disease	0.00277	0.021	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—MICA—Behcet's disease	0.00271	0.0205	CbGpPWpGaD
Pranlukast—MUC2—spinal cord—Behcet's disease	0.00256	0.0828	CbGeAlD
Pranlukast—NFKB1—eye—Behcet's disease	0.00229	0.0739	CbGeAlD
Pranlukast—MUC2—nervous system—Behcet's disease	0.00216	0.0698	CbGeAlD
Pranlukast—TNF—amb2 Integrin signaling—ITGB2—Behcet's disease	0.00211	0.016	CbGpPWpGaD
Pranlukast—MUC2—central nervous system—Behcet's disease	0.00208	0.0672	CbGeAlD
Pranlukast—IL5—Allograft Rejection—CTLA4—Behcet's disease	0.00206	0.0156	CbGpPWpGaD
Pranlukast—IL5—IL4-mediated signaling events—IL10—Behcet's disease	0.00194	0.0147	CbGpPWpGaD
Pranlukast—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—CTLA4—Behcet's disease	0.00186	0.0141	CbGpPWpGaD
Pranlukast—NFKB1—mammalian vulva—Behcet's disease	0.00181	0.0587	CbGeAlD
Pranlukast—TNF—IL27-mediated signaling events—STAT4—Behcet's disease	0.0018	0.0136	CbGpPWpGaD
Pranlukast—CYSLTR1—mammalian vulva—Behcet's disease	0.00178	0.0576	CbGeAlD
Pranlukast—NFKB1—IL23-mediated signaling events—STAT4—Behcet's disease	0.00178	0.0135	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—IL10—Behcet's disease	0.00176	0.0133	CbGpPWpGaD
Pranlukast—NFKB1—cardiac atrium—Behcet's disease	0.00174	0.0562	CbGeAlD
Pranlukast—MUC2—brain—Behcet's disease	0.00165	0.0534	CbGeAlD
Pranlukast—IL5—Allograft Rejection—IL10—Behcet's disease	0.0016	0.0121	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—IL10—Behcet's disease	0.00157	0.0119	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—HLA-B—Behcet's disease	0.00152	0.0115	CbGpPWpGaD
Pranlukast—NFKB1—Oxidative Stress—CAT—Behcet's disease	0.00149	0.0113	CbGpPWpGaD
Pranlukast—NFKB1—TSLP Signaling Pathway—STAT4—Behcet's disease	0.00147	0.0111	CbGpPWpGaD
Pranlukast—IL5—Cytokines and Inflammatory Response—TNF—Behcet's disease	0.00144	0.0109	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—APOB—Behcet's disease	0.00138	0.0104	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—STAT4—Behcet's disease	0.00136	0.0103	CbGpPWpGaD
Pranlukast—NFKB1—IL1 and megakaryotyces in obesity—ICAM1—Behcet's disease	0.0013	0.00987	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.00126	0.00955	CbGpPWpGaD
Pranlukast—NFKB1—nervous system—Behcet's disease	0.00123	0.0398	CbGeAlD
Pranlukast—NFKB1—IL12-mediated signaling events—STAT4—Behcet's disease	0.00121	0.00917	CbGpPWpGaD
Pranlukast—CYSLTR1—nervous system—Behcet's disease	0.00121	0.0391	CbGeAlD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—ICAM1—Behcet's disease	0.0012	0.00909	CbGpPWpGaD
Pranlukast—NFKB1—central nervous system—Behcet's disease	0.00119	0.0383	CbGeAlD
Pranlukast—TNF—Cytokines and Inflammatory Response—IL10—Behcet's disease	0.00117	0.00886	CbGpPWpGaD
Pranlukast—CYSLTR1—central nervous system—Behcet's disease	0.00116	0.0376	CbGeAlD
Pranlukast—TNF—amb2 Integrin signaling—APOB—Behcet's disease	0.00105	0.00795	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—ICAM1—Behcet's disease	0.00103	0.00784	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—SERPINE1—Behcet's disease	0.00101	0.00767	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00097	0.00735	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—CXCL8—Behcet's disease	0.000963	0.0073	CbGpPWpGaD
Pranlukast—NFKB1—EBV LMP1 signaling—CXCL8—Behcet's disease	0.000954	0.00723	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—ITGB2—Behcet's disease	0.000951	0.00721	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—APOB—Behcet's disease	0.000948	0.00718	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—CAT—Behcet's disease	0.000942	0.00713	CbGpPWpGaD
Pranlukast—NFKB1—brain—Behcet's disease	0.000941	0.0304	CbGeAlD
Pranlukast—CYSLTR1—brain—Behcet's disease	0.000924	0.0299	CbGeAlD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.000918	0.00696	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.000878	0.00665	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—CXCL8—Behcet's disease	0.000874	0.00663	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—Behcet's disease	0.000854	0.00647	CbGpPWpGaD
Pranlukast—IL5—Glucocorticoid receptor regulatory network—CXCL8—Behcet's disease	0.000849	0.00643	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.000847	0.00642	CbGpPWpGaD
Pranlukast—TNF—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.000846	0.00641	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.000831	0.0063	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—CAT—Behcet's disease	0.000795	0.00602	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—ICAM1—Behcet's disease	0.000788	0.00597	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—APOB—Behcet's disease	0.000771	0.00585	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.00075	0.00568	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—ITGB2—Behcet's disease	0.00075	0.00568	CbGpPWpGaD
Pranlukast—TNF—EBV LMP1 signaling—CXCL8—Behcet's disease	0.000726	0.00551	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—APOB—Behcet's disease	0.000722	0.00547	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.000713	0.0054	CbGpPWpGaD
Pranlukast—ABCC2—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000704	0.00534	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—ITGAL—Behcet's disease	0.000676	0.00513	CbGpPWpGaD
Pranlukast—NFKB1—RANKL/RANK Signaling Pathway—ICAM1—Behcet's disease	0.000671	0.00508	CbGpPWpGaD
Pranlukast—NFKB1—Canonical NF-kappaB pathway—TNF—Behcet's disease	0.000664	0.00503	CbGpPWpGaD
Pranlukast—NFKB1—EBV LMP1 signaling—TNF—Behcet's disease	0.000664	0.00503	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CTLA4—Behcet's disease	0.000637	0.00482	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCR1—Behcet's disease	0.000633	0.00479	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—CAT—Behcet's disease	0.000631	0.00478	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—APOB—Behcet's disease	0.000613	0.00464	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—APOA1—Behcet's disease	0.00061	0.00462	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—TNF—Behcet's disease	0.000609	0.00461	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—CAT—Behcet's disease	0.000605	0.00459	CbGpPWpGaD
Pranlukast—IL5—Immune System—MEFV—Behcet's disease	0.000596	0.00452	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000595	0.00451	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—APOB—Behcet's disease	0.000588	0.00445	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—ICAM1—Behcet's disease	0.00058	0.00439	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.000578	0.00438	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.000572	0.00433	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000571	0.00433	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.000569	0.00431	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000553	0.00419	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.000543	0.00411	CbGpPWpGaD
Pranlukast—NFKB1—TSLP Signaling Pathway—CXCL8—Behcet's disease	0.000538	0.00408	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CAT—Behcet's disease	0.000532	0.00403	CbGpPWpGaD
Pranlukast—IL5—Immune System—ERAP1—Behcet's disease	0.000532	0.00403	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—TNF—Behcet's disease	0.00051	0.00386	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CCR1—Behcet's disease	0.000498	0.00378	CbGpPWpGaD
Pranlukast—NFKB1—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Behcet's disease	0.000497	0.00377	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL10—Behcet's disease	0.000495	0.00375	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—SERPINE1—Behcet's disease	0.00049	0.00372	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—ICAM1—Behcet's disease	0.000487	0.00369	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000485	0.00367	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—SERPINE1—Behcet's disease	0.000484	0.00367	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—CAT—Behcet's disease	0.000481	0.00364	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—HLA-B—Behcet's disease	0.000471	0.00357	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—APOB—Behcet's disease	0.000467	0.00354	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—APOA1—Behcet's disease	0.000465	0.00352	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—NOS3—Behcet's disease	0.000463	0.0035	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000461	0.00349	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—TNF—Behcet's disease	0.000454	0.00344	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000454	0.00344	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000453	0.00344	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCR1—Behcet's disease	0.000452	0.00343	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000449	0.0034	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—ICAM1—Behcet's disease	0.000442	0.00335	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.00044	0.00333	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.000433	0.00328	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—CXCL8—Behcet's disease	0.000421	0.00319	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—NOS3—Behcet's disease	0.000418	0.00316	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MEFV—Behcet's disease	0.000416	0.00315	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—TNF—Behcet's disease	0.00041	0.00311	CbGpPWpGaD
Pranlukast—IL5—Immune System—ITGB2—Behcet's disease	0.000393	0.00298	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.00039	0.00296	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000385	0.00292	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000381	0.00289	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNF—Behcet's disease	0.000381	0.00289	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.000377	0.00286	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—APOB—Behcet's disease	0.000372	0.00282	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000369	0.0028	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—SERPINE1—Behcet's disease	0.000369	0.0028	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—TNF—Behcet's disease	0.000368	0.00279	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CCR1—Behcet's disease	0.000358	0.00271	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—Behcet's disease	0.000357	0.0027	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERAP1—Behcet's disease	0.000356	0.0027	CbGpPWpGaD
Pranlukast—IL5—Immune System—ITGAL—Behcet's disease	0.000355	0.00269	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—NOS3—Behcet's disease	0.000355	0.00269	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—Behcet's disease	0.000351	0.00266	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000351	0.00266	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—CXCL8—Behcet's disease	0.000345	0.00261	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—Behcet's disease	0.00034	0.00258	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—Behcet's disease	0.000335	0.00254	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.00033	0.0025	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCR1—Behcet's disease	0.000325	0.00246	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—CXCL8—Behcet's disease	0.000315	0.00238	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—APOA1—Behcet's disease	0.000294	0.00223	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000293	0.00222	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—CXCL8—Behcet's disease	0.000292	0.00221	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.00029	0.00219	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.000287	0.00218	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—Behcet's disease	0.000286	0.00216	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—Behcet's disease	0.000283	0.00214	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—ICAM1—Behcet's disease	0.000278	0.0021	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ITGB2—Behcet's disease	0.000274	0.00208	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—Behcet's disease	0.000272	0.00206	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CXCL8—Behcet's disease	0.000271	0.00205	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR1—Behcet's disease	0.000267	0.00203	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ITGB2—Behcet's disease	0.000263	0.002	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CAT—Behcet's disease	0.000262	0.00199	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—Behcet's disease	0.000252	0.00191	CbGpPWpGaD
Pranlukast—CYP3A4—nervous system—Behcet's disease	0.000246	0.00794	CbGeAlD
Pranlukast—IL5—Immune System—CTLA4—Behcet's disease	0.000244	0.00185	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MEFV—Behcet's disease	0.000242	0.00184	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ITGAL—Behcet's disease	0.000238	0.0018	CbGpPWpGaD
Pranlukast—CYP3A4—central nervous system—Behcet's disease	0.000236	0.00764	CbGeAlD
Pranlukast—NFKB1—Apoptosis—TNF—Behcet's disease	0.000235	0.00178	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000235	0.00178	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SERPINE1—Behcet's disease	0.000234	0.00177	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—NOS3—Behcet's disease	0.000234	0.00177	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—Behcet's disease	0.000227	0.00172	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.000226	0.00171	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000225	0.0017	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NOS3—Behcet's disease	0.000223	0.00169	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.000221	0.00167	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—Behcet's disease	0.000219	0.00166	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.000218	0.00165	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERAP1—Behcet's disease	0.000216	0.00164	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—SERPINE1—Behcet's disease	0.000215	0.00163	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000209	0.00158	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000206	0.00156	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	0.000202	0.00153	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CXCL8—Behcet's disease	0.000196	0.00149	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR1—Behcet's disease	0.000192	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000183	0.00138	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-B—Behcet's disease	0.000181	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CXCL8—Behcet's disease	0.000179	0.00136	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.000172	0.00131	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CTLA4—Behcet's disease	0.000164	0.00124	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGB2—Behcet's disease	0.00016	0.00121	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL8—Behcet's disease	0.000159	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.000157	0.00119	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000157	0.00119	CbGpPWpGaD
Pranlukast—IL5—Immune System—ICAM1—Behcet's disease	0.000147	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGAL—Behcet's disease	0.000144	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—Behcet's disease	0.000144	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CXCL8—Behcet's disease	0.000135	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—Behcet's disease	0.000135	0.00102	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOB—Behcet's disease	0.000126	0.000956	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HLA-B—Behcet's disease	0.000126	0.000955	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL8—Behcet's disease	0.000125	0.000948	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000122	0.000925	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-B—Behcet's disease	0.000121	0.000917	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL8—Behcet's disease	0.000114	0.000861	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR1—Behcet's disease	0.000109	0.000823	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOA1—Behcet's disease	9.98e-05	0.000756	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTLA4—Behcet's disease	9.92e-05	0.000752	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ICAM1—Behcet's disease	9.83e-05	0.000745	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—APOB—Behcet's disease	9.3e-05	0.000705	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOB—Behcet's disease	9.05e-05	0.000686	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—Behcet's disease	8.98e-05	0.00068	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—Behcet's disease	8.15e-05	0.000618	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SERPINE1—Behcet's disease	7.92e-05	0.0006	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—Behcet's disease	7.56e-05	0.000573	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.36e-05	0.000558	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-B—Behcet's disease	7.34e-05	0.000556	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOA1—Behcet's disease	7.16e-05	0.000543	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—Behcet's disease	6.71e-05	0.000508	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ICAM1—Behcet's disease	5.96e-05	0.000452	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—Behcet's disease	5.71e-05	0.000432	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SERPINE1—Behcet's disease	5.69e-05	0.000431	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—Behcet's disease	5.43e-05	0.000411	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOB—Behcet's disease	5.13e-05	0.000388	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—Behcet's disease	4.82e-05	0.000365	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.3e-05	0.000326	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOA1—Behcet's disease	4.06e-05	0.000307	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.4e-05	0.000258	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—Behcet's disease	3.22e-05	0.000244	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—Behcet's disease	3.07e-05	0.000233	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—Behcet's disease	2.73e-05	0.000207	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CAT—Behcet's disease	1.97e-05	0.000149	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOB—Behcet's disease	1.91e-05	0.000145	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA1—Behcet's disease	1.51e-05	0.000115	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CAT—Behcet's disease	1.3e-05	9.85e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOB—Behcet's disease	1.26e-05	9.56e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—Behcet's disease	1.15e-05	8.69e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA1—Behcet's disease	9.98e-06	7.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—Behcet's disease	7.57e-06	5.73e-05	CbGpPWpGaD
